Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.
VBI is developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
Building The Nations Leading Wound Care Team
Kotter International is a strategy execution and change firm. We work with you to engage your people around executing a strategic goal or change.
Quantitative RNA & Specialty DNA Sequencing Solutions.
